The Atlantic

The 7 Most Revealing Moments From a Major Drug-Pricing Hearing

Even pharma executives recognize that drugs cost Americans too much.
Source: Jacquelyn Martin / AP

When a lawmaker compares the way your company protects its profits to how Gollum protects his ring, you know it’s not going to be a fun four hours.

That is how Senator Ron Wyden of Oregon on Tuesday referred to the way the drugmaker AbbVie protects the exclusivity of its prize drug, Humira. The comment foreshadowed the way the Senate Finance Committee would grill seven pharmaceutical-company CEOs about a topic that has stirred bipartisan ire: Why, exactly, are drug prices so high?

To name just one example,, . The price of the insulin drug Lantus rose . The struggle of patients to afford treatments such as and has been well publicized.

You're reading a preview, sign up to read more.

More from The Atlantic

The Atlantic4 min readPolitics
Seven Questions That Need Answers Before Any Attack on Iran
President Trump’s threats of retaliation for strikes on Saudi oil facilities seem premature.
The Atlantic6 min readScience
When One Big Cat Is Almost Like the Other
India’s Supreme Court has to decide if African cheetahs could sub in for the country’s long-lost population of Asiatic cheetahs.
The Atlantic7 min readPsychology
The Price of Ascending America’s Class Ladder
Being upwardly mobile can come at a cost to people’s relationships with the family, friends, and community they grew up with.